Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy for stroke.

Sean I Savitz1, Jonathan H Dinsmore, Lawrence R Wechsler

  • 1Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. ssavitz@bidmc.harvard.edu

Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|February 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Locked-in syndrome.

Handbook of clinical neurology·2026
Same author

Methodological considerations in PISCES 3: a randomized, placebo-controlled study of intracerebral stem cells in subjects with disability following an ischemic stroke.

Frontiers in stroke·2026
Same author

Transient ischemic attack in the twenty first century: is it still a useful construct?

Frontiers in stroke·2026
Same author

Competition between a transmembrane helix on Scap and a membrane cholesterol regulates Scap-Insig interaction and SREBP activation.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled Trial.

Stroke·2025
Same author

Structural mechanism of CB<sub>1</sub>R binding to peripheral and biased inverse agonists.

Nature communications·2024
Same journal

Pediatric neurotherapy.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2013
Same journal

Drug development in critical times.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
Same journal

Spinal muscular atrophy: a test case for drug development in orphan diseases.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
Same journal

Community neurorehabilitation: a synthesis of current evidence and future research directions.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
Same journal

Issues in selecting outcome measures to assess functional recovery after stroke.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
Same journal

Behavioral tests for preclinical intervention assessment.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
See all related articles

Cell transplantation shows promise for stroke recovery in animal and human studies. Research is exploring various stem cell sources to improve outcomes for stroke patients.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Clinical Neurology

Background:

  • Cell transplantation is being investigated for stroke recovery.
  • Animal models show enhanced recovery after focal cerebral ischemia.
  • Clinical trials are evaluating neuronal cell lines and fetal neurons for stroke patients.

Purpose of the Study:

  • To review preclinical and clinical studies on cell therapy for stroke.
  • To highlight current knowledge gaps in implant source biology.
  • To discuss stroke-specific factors influencing cell therapy success.

Main Methods:

  • Review of preclinical studies on various human stem cell sources (brain, bone marrow, umbilical cord, adipose).
  • Analysis of clinical trials using immortalized neuronal cell lines and porcine fetal neurons.

Related Experiment Videos

  • Discussion of biological factors and stroke conditions impacting cell transplantation.
  • Main Results:

    • Growing evidence supports cell transplantation for stroke recovery in animal models.
    • Clinical investigations are underway for specific cell types in chronic stroke.
    • Understanding of implant biology and stroke environment remains limited.

    Conclusions:

    • Cell therapy holds potential for stroke treatment.
    • Further research is needed on stem cell biology and stroke conditions.
    • Optimizing cell sources and delivery is crucial for clinical success.